THIS SERVICE IS NOT AVAILABLE IN YOUR REGION

COPOLAC

Uruguay

Founded in

1986 (40 Years)

Founded

Last online: No recent activity

Claim company Visit website

TrustScore unavailableNot enough score to display the trend.

Be the first to rate and review this company.

OVERALL SCORE

Others

--/10

Reviews

--/90

0 reviews

Provided by TrustFinance

TrustScore unavailableNot enough score to display the trend.

Be the first to rate and review this company.

FTD LIMITED

(505 reviews)

British Virgin Islands

2017

(9 years)

Security Information :

BVI FSC

Security Information

Warning

This company is currently Unproved.

Please be cautious of the potential risks!

License

A Grade License

Issued by globally renowned regulators, these licenses ensure the highest trader protection through strict compliance, fund segregation, insurance, and regular audits. Dispute resolution and adherence to AML/CTF standards further enhance security.

B Grade License

Granted by respected regional regulators, these licenses offer robust safety measures such as fund segregation, financial reporting, and compensation schemes. Though slightly less strict than Tier 1, they provide dependable regional protection.

C Grade License

Issued by regulators in emerging markets, these licenses offer basic protections such as minimum capital requirements and AML policies. Oversight is less stringent, so traders should exercise caution and verify safety measures.

D Grade License

From jurisdictions with minimal oversight, these licenses often lack key protections like fund segregation and insurance. While attractive for operational flexibility, they pose higher risks to traders.

Company Information

Get to know COPOLAC

Company Information

Get to know COPOLAC

COPOLAC is an international cooperation programme funded by the European Union, currently in its third phase (COPOLAC III). Its mission is to foster bi-regional dialogue and collaboration between the EU and CELAC (Community of Latin American and Caribbean States) countries to tackle the global drug problem. The programme focuses on strengthening public institutions, promoting evidence-based policies, and addressing the drug issue from a comprehensive perspective that includes public health, security, development, and human rights. It is implemented by the FIIAPP (International and Ibero-American Foundation for Administration and Public Policies) and the IILA (Italo-Latin American International Organization), in partnership with other key agencies.

Industry